CONTENTS:
- Enacting 'more-than-human' care: Clients' and counsellors' views on the multiple affordances of chatbots in alcohol and other drug counselling. Barnett A., Savic M., Pienaar K., Carter A., Warren N., Sandral E., et al., art. 102910.
- A normalised future of addiction. Keane H., art. 102972.
- Beyond a 'post-cure' world: Sketches for a new futurology of hepatitis C. Seear K., Fraser S., Farrugia A., valentine k., art. 103042.
- History and the future of addiction. Berridge V., art. 103054.
- Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin. Reuter P., Pardo B., Taylor J., art. 103086.
- Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl. Caulkins J.P., art. 103162.
- Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 "lockdown": A qualitative study in the United States. Giovenco D.P., Spillane T.E., Maggi R.M., Lee E.Y., Philbin M.M., art. 103175.
- "Is it banned? Is it illegal?": Navigating Western Australia's regulatory environment for e-cigarettes. McCausland K., Maycock B., Leaver T., Wolf K., Freeman B., Jancey J., art. 103177.
- Developing explanatory models for life course shifts in the burden of substance use to inform future policy and practice. Kelly B.C., Vuolo M., art. 103182.
- The role of alcohol use and cigarette smoking in sickness absence: Are there social inequalities? Lund I., Moan I.S., art. 103190.
- A comparative analysis of laws on recreational cannabis edibles between Canada and the United States of America. Goundar P., Macaulay T., Szafron M., art. 103191.
- An application of agent-based modeling to explore the impact of decreasing incarceration rates and increasing drug treatment access on sero-discordant partnerships among people who inject drugs. Linton S.L., Jarlais D.C.D., Ornstein J.T., Kasman M., Hammond R., Kianian B., et al., art. 103194.
- Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs. Park J.N., Frankel S., Morris M., Dieni O., Fahey-Morrison L., Luta M., et al., art. 103196.
- Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs. Jawa R., Stein M.D., Anderson B., Liebschutz J.M., Stewart C., Phillips K.T., et al., art. 103198.
- A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic. French R., Favaro J., Aronowitz S.V., art. 103199.
- "I wanted to close the chapter completely... and I feel like that [carrying naloxone] would keep it open a little bit": Refusal to carry naloxone among newly-abstinent opioid users and 12-step identity. Bowles J.M., Smith L.R., Mittal M.L., Harding R.W., Copulsky E., Hennessy G., et al., art. 103200.
- How medical are states' medical cannabis policies?: Proposing a standardized scale. Richard E.L., Althouse A.D., Arnsten J.H., Bulls H.W., Kansagara D., Kerbag M.N., et al., art. 103202.
- A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison. Palmer A., Papaluca T., Stoové M., Winter R., Pedrana A., Hellard M., et al., art. 103203.
- Substance use among refugees in three Lebanese camps: A cross-sectional study. Abbas Z., Eiden C., Salameh P., Peyriere H., art. 103204.
- Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use. Artenie A.A., Fortier E., Sylvestre M.-P., Hoj S.B., Minoyan N., Gauvin L., et al., art. 103205.
- A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia. Pollini R.A., Paquette C.E., Drvar T., Marshalek P., Ang-Rabanes M., Feinberg J., et al., art. 103206.
- Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information. Liberman A.R., Bromberg D.J., Azbel L., Rozanova J., Madden L., Meyer J.P., et al., art. 103209.
- Monitoring drug trends in the digital environment - New methods, challenges and the opportunities provided by automated approaches. Guarita B., Belackova V., van der Gouwe D., Blankers M., Pazitny M., Griffiths P., art. 103210.
- The emerging norms of e-cigarette use among adolescents: A meta-ethnography of qualitative evidence. Smith H., Lucherini M., Amos A., Hill S., art. 103227.
- "Undisciplined" drinking, multi-sectoralism and political power: Examining problematisations in the Botswana alcohol policy. Sebeelo T.B., art. 103228.
- Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex. Treloar C., Hopwood M., Drysdale K., Lea T., Holt M., Dowsett G.W., et al., art. 103229.
- Unity in diversity: A systematic review on the GHB using population. Dijkstra B.A.G., Beurmanjer H., Goudriaan A.E., Schellekens A.F.A., Joosten E.A.G., art. 103230.
- Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres. Morales-Arraez D., Hernandez-Bustabad A., Medina-Alonso M.J., Santiago-Gutiérrez L.G., Garcia-Gil S., Diaz-Flores F., et al., art. 103235.
- Substance use prevention interventions for children and young people in Sub-Saharan Africa: A systematic review. Saba O.A., Weir C., Aceves-Martins M., art. 103251.
- Harms to children from the financial effects of others' drinking. Laslett A.-M., Mojica-Perez Y., Waleewong O., Hanh H.T.M., Jiang H., art. 103254.
- Reprint of: Biotechnologies and the future of opioid addiction treatments. Wolfe D., Saucier R., art. 103273.
- Futures-oriented drugs policy research: Events, trends, and speculating on what might become. Rhodes T., Lancaster K., art. 103332.
- Mapping drug epidemiology futures. Larney S., Jones H., Rhodes T., Hickman M., art. 103378.